THE PRIX GALIEN USA
 |
Improving the Human Condition
"...considered the industry's equivalent of the Nobel Prize..."
THE PRIX GALIEN USA 2008 WINNERS
The Prix Galien USA 2008 winners include:
Best Pharmaceutical Agent (Small Molecule)
- Selzentry™ (Pfizer Inc.)
- Isentress® (Merck & Co., Inc.)
Best Biotechnology Agent
- SolirisTM (Alexion Pharmaceuticals, Inc.)
- INFUSE® (Wyeth)
Special Therapeutic Development
- The Celgene Corporation for Revlimid®
Pro Bono Humanum Award
- Sheldon Segal, distinguished scientist at the Population Council
The Prix Galien recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is now considered the industry’s equivalent of the Nobel Prize, the highest accolade for pharmaceutical research and development.
The Prix Galien was inaugurated in the United States in September 2007 under the auspices of an exceptional awards committee that includes 6 Nobel Laureates.
Sponsorship Opportunities for the 2009 Awards Ceremony
Limited sponsorship opportunities are available.
Contact Marian Temesvary at (312) 422-0405 or mtemesvary@prix-galien-usa.com
From President Jimmy Carter, September 21, 2007
"To Dr. Roy Vagelos:
Rosalynn joins me in congratulating you on receiving the 2007 Galien Pro Bono Humanum Prize
at the Prix Galien Awards Ceremony. We always have been inspired by your decision,
on behalf
of Merck & Co., Inc., to donate Mectizan® free of charge to all who need it
for as long
as necessary."
From Michael Bloomberg, Mayor of New York City. September 25, 2007
"Dear Friends:
It is a pleasure to welcome everyone to the first Prix Galien USA Awards Ceremony. Since its
establishment in France in 1970, the prestigious Prix Galien has honored leaders whose groundbreaking
work in the pharmaceutical and biomedical sectors have improved the health and quality of life for
countless men and women around the globe."
